Abingworth

Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

176

Average round size

38M

Portfolio companies

109

Rounds per year

3.45

Lead investments

23

Follow on index

0.38

Exits

71

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

Abingworth is the famous VC, which was founded in 1973. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined VC is situated in the London.

Besides them, we counted 12 critical employees of this fund in our database.

Among the various public portfolio startups of the fund, we may underline Pharmion, Algeta, Senseonics The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Biopharma.

Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2014. Comparing to the other companies, this Abingworth performs on 18 percentage points more the average number of lead investments. The average startup value when the investment from Abingworth is 5-10 millions dollars. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Abingworth, startups are often financed by Versant Ventures, SR One, InterWest Partners. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, Wellcome Trust, Frazier Healthcare Partners. In the next rounds fund is usually obtained by MPM Capital, InterWest Partners, Versant Ventures.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtech
Stage focus
Seed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 38 more
Check size
15M — 30M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 356000000
Fund raised date
2023-10-30

Analytics

Total investments
176
Lead investments
23
Exits
71
Rounds per year
3.45
Follow on index
0.38
Investments by industry
  • Biotechnology (140)
  • Health Care (103)
  • Medical (58)
  • Pharmaceutical (57)
  • Therapeutics (38)
  • Show 37 more
Investments by region
  • United States (117)
  • United Kingdom (25)
  • France (8)
  • Switzerland (7)
  • Latvia (4)
  • Show 8 more
Peak activity year
2009
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
4

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
107M
Group Appearance index
0.91
Avg. company exit year
14
Avg. multiplicator
1.72
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Entos 18 Jun 2024 Software, Artificial Intelligence, Machine Learning Early Stage Venture 50M United States, California, Los Angeles
Personalis 13 Jan 2015 Biotechnology, Health Care, Health Diagnostics, Genetics Late Stage Venture 33M United States, California

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.